PRIMA-NIRS: Restoring Central Motor Control Extension

Sponsor
University of Pittsburgh (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04302831
Collaborator
National Institute on Aging (NIA) (NIH)
0
1
2
8.9
0

Study Details

Study Description

Brief Summary

Motor skill training therapy aims to improve the brain's control of walking and can improve clinic-based measures of walking in older adults. However, it is unknown whether the benefits of motor skill training extend to real world mobility measures. The investigators will test the effects of motor skill training on measures of community mobility of older adults and assess the mechanisms through improved motor control at the level of the brain. These results will inform intervention approaches to maintain community mobility of older adults and prevent disability and institutionalization.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Strength training
  • Behavioral: Endurance training
  • Behavioral: Flexibility training
  • Behavioral: Physical activity behavioral intervention
  • Behavioral: Task Specific timing and coordination training
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Restoring Central Motor Control to Improve Community Mobility of Older Adults
Actual Study Start Date :
Mar 4, 2020
Actual Primary Completion Date :
Dec 1, 2020
Actual Study Completion Date :
Dec 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard

The standard arm consists of strength, endurance and flexibility exercises 2 times per week for 12 weeks. Will also receive a physical activity behavioral intervention.

Behavioral: Strength training
weight lifting to increase muscle strength

Behavioral: Endurance training
treadmill walking to increase endurance

Behavioral: Flexibility training
stretches to improve flexibility

Behavioral: Physical activity behavioral intervention
Intervention to encourage participants to be more physically active

Experimental: Standard-plus

The standard-plus arm consists of strength, endurance and flexibility exercises plus task specific timing and coordination exercises to improve gait 2 times per week for 12 weeks. Will also receive a physical activity behavioral intervention.

Behavioral: Strength training
weight lifting to increase muscle strength

Behavioral: Endurance training
treadmill walking to increase endurance

Behavioral: Flexibility training
stretches to improve flexibility

Behavioral: Physical activity behavioral intervention
Intervention to encourage participants to be more physically active

Behavioral: Task Specific timing and coordination training
stepping and walking patterns to improve timing and coordination of gait

Outcome Measures

Primary Outcome Measures

  1. Change in oxygenated hemoglobin at the prefrontal cortex from standing to walking [change from baseline to 12 weeks]

    Physiologic measure indicative of usage of the prefrontal cortex during a task recorded by optical imaging (near infrared spectroscopy).

  2. Change in oxygenated hemoglobin at the prefrontal cortex from standing to walking [change from baseline to 36 weeks]

    Physiologic measure indicative of usage of the prefrontal cortex during a task recorded by optical imaging (near infrared spectroscopy).

Secondary Outcome Measures

  1. Gait speed [12, 24, and 36 weeks]

    Walking speed (m/s) during usual pace

  2. Gait speed [12, 24, and 36 weeks]

    Walking speed (m/s) with a cognitive challenge.

  3. Gait speed [12, 24, and 36 weeks]

    Walking speed (m/s) on an uneven surface.

  4. Gait variability [12, 24, and 36 weeks]

    Fluctuations in gait characteristics from step to step during usual pace. Physiologic measure of temporal gait characteristics (standard deviation).

  5. Gait variability [12, 24, and 36 weeks]

    Fluctuations in gait characteristics from step to step while walking with a cognitive challenge. Physiologic measure of temporal gait characteristics (standard deviation).

  6. Gait variability [12, 24, and 36 weeks]

    Fluctuations in gait characteristics from step to step while walking on an uneven surface. Physiologic measure of temporal gait characteristics (standard deviation).

Other Outcome Measures

  1. Activity Space [12, 24, and 36 weeks]

    Extent of travel beyond the home collected by GPS device based on a standard deviation ellipse of spatial measurement points.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 65 years of age and older

  • Ambulatory without an assistive device or the assistance of another person

  • Usual 4 meter gait speed > 0.60 m/s and < 1.2 m/s

  • Physician clearance to participate in a moderate intensity exercise program

  • Not meeting physical activity recommendations defined as reporting less than 150 minutes of moderate intensity activity per week in the past month.

Exclusion Criteria:
  • persistent lower extremity pain that is present on most days of the week

  • back pain that is present on most days of the weeks and interferes with walking and - activities of daily living or back pain that increases with walking

  • refuse to walk on a treadmill

  • plans to move out of the area in the next 5 years

  • dyspnea at rest or during activities of daily living or use supplemental oxygen (CHF, COPD)

  • any acute illness or medical condition that is not stable according to the approving physician

  • resting systolic blood pressure ≥ 200 mm Hg or diastolic blood pressure ≥ 100 mm Hg or resting heart rate > 100 or < 40 beats per minute

  • diagnosed dementia or cognitive impairment defined as modified Mini-Mental State (3MS) examination <79

  • hospitalized in the past 6 months for acute illness or surgery, other than minor surgical procedures

  • severe visual impairment f- ixed or fused lower extremity joints such as hip, knee or ankle

  • lower extremity strength <3/5 on manual muscle testing

  • lower extremity amputation

  • progressive movement disorder such as Multiple Sclerosis, Amyotrophic Lateral Sclerosis or Parkinson's disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pittsburgh Pittsburgh Pennsylvania United States 15219

Sponsors and Collaborators

  • University of Pittsburgh
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Andrea L Rosso, PhD, MPH, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andrea Rosso, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04302831
Other Study ID Numbers:
  • STUDY19110142
  • R01AG057671-01A1
First Posted:
Mar 10, 2020
Last Update Posted:
Mar 16, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2021